-- UBS upgraded Swiss online pharmacy Galenica (GALE.SW) to neutral from sell, while maintaining the price target at 85 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)